BBCMF (Lir Life Sciences) Total Equity: $0.77 Mil (As of Jan. 2026)


BBCMF Lir Life Sciences Corp BBCMF
15 GF Score
Price $0.05
View Full Analysis

What is Lir Life Sciences Total Equity?

Lir Life Sciences BBCMF -80.00% 15 Total Equity is $0.77 Mil as of Jan. 2026. GuruFocus rates BBCMF with a GF Score™ of 15/100.

Lir Life Sciences's total equity for the quarter that ended in Jan. 2026 was $0.77 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Lir Life Sciences Total Equity Historical Data

* Premium members only.

The historical data trend for Lir Life Sciences's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lir Life Sciences Total Equity Chart

Lir Life Sciences Annual Data
Trend Apr24 Apr25
Total Equity
-0.02 -0.06

Lir Life Sciences Quarterly Data
Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Total Equity Get a 7-Day Free Trial 0.00 -0.06 -0.21 1.07 0.77
BBCMF
15GF Score
Lir Life Sciences Corp BBCMF
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lir Life Sciences Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Lir Life Sciences's Total Equity for the fiscal year that ended in Apr. 2025 is calculated as

Total Equity=Total Assets(Q: Apr. 2025 )-Total Liabilities(Q: Apr. 2025 )
=0.087-0.145
=-0.06

Lir Life Sciences's Total Equity for the quarter that ended in Jan. 2026 is calculated as

Total Equity=Total Assets(Q: Jan. 2026 )-Total Liabilities(Q: Jan. 2026 )
=0.829-0.057
=0.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $0.77 Mil mean?
Lir Life Sciences (BBCMF) has a Total Equity of $0.77 Mil as of Jan. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Lir Life Sciences and its competitors.
Is Lir Life Sciences' Total Equity too high?
Lir Life Sciences' current Total Equity is $0.77 Mil. Overall, Lir Life Sciences has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Lir Life Sciences' Total Equity compare to VRTX and REGN?
Lir Life Sciences' Total Equity of $0.77 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Lir Life Sciences and its competitors. Lir Life Sciences's current Total Equity is $0.77 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lir Life Sciences stock overvalued right now?
Lir Life Sciences (BBCMF) has a current Total Equity of $0.77 Mil. The current Total Equity is $0.77 Mil. Lir Life Sciences' overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Lir Life Sciences (BBCMF), the current Total Equity is $0.77 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lir Life Sciences Business Description

Other Exchanges N790:GermanySKNY:Canada
Address 505-1505 West 2nd Avenue, Vancouver, BC, CAN, V6J 1H2
Lir Life Sciences Corp is a biotechnology company developing transdermal and sublingual drug-delivery technologies for GLP-1-based obesity therapies, with the focus of improving accessibility and patient experience.
15GF Score

Get the complete analysis for BBCMF

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.05
Price